Soleno Therapeutics Inc (SLNO) — Top EPS Revision Performer
As of 2026-05-05, Soleno Therapeutics Inc (SLNO) has a next-year EPS growth estimate of 59.18%. Featured in 2 EPS revision reports, most recently on 2026-04-13. Sector: Healthcare.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 59.18%
- EPS growth this year
- 912.39%
- EPS next quarter (est)
- $0.68
- Last price
- $52.92
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-05-05 | 59.18% | 912.39% | $0.68 | $52.92 |
| 2026-05-04 | 59.18% | 912.39% | $0.68 | $52.90 |
| 2026-05-03 | 59.18% | 912.39% | $0.68 | $52.87 |
| 2026-04-30 | 59.18% | 912.39% | $0.68 | $52.82 |
| 2026-04-29 | 59.18% | 912.39% | $0.68 | $52.78 |
| 2026-04-28 | 59.18% | 912.39% | $0.68 | $52.76 |
| 2026-04-27 | 59.18% | 912.39% | $0.68 | $52.75 |
| 2026-04-26 | 59.18% | 912.39% | $0.68 | $52.72 |
| 2026-04-24 | 59.18% | 912.39% | $0.68 | $52.72 |
| 2026-04-23 | 59.18% | 912.39% | $0.68 | $52.83 |
| 2026-04-22 | 59.18% | 912.39% | $0.68 | $52.75 |
| 2026-04-21 | 59.18% | 912.39% | $0.68 | $52.69 |
| 2026-04-20 | 59.18% | 912.39% | $0.68 | $52.67 |
| 2026-04-19 | 59.18% | 912.39% | $0.68 | $52.78 |
| 2026-04-16 | 59.18% | 912.39% | $0.68 | $52.57 |
| 2026-04-15 | 59.18% | 912.39% | $0.68 | $52.57 |
| 2026-04-14 | 59.18% | 912.39% | $0.68 | $52.62 |
| 2026-04-13 | 59.18% | 912.39% | $0.68 | $52.64 |
| 2026-04-12 | 59.18% | 912.39% | $0.68 | $52.63 |
| 2026-04-10 | 59.18% | 912.39% | $0.68 | $52.51 |
| 2026-04-09 | 59.18% | 912.39% | $0.68 | $52.51 |
| 2026-04-08 | 59.18% | N/A | $0.68 | $52.60 |
| 2026-04-07 | 59.18% | N/A | $0.68 | $52.35 |
| 2026-04-06 | 59.18% | N/A | $0.68 | $52.35 |
| 2026-04-05 | 68.66% | N/A | $0.66 | $39.49 |
| 2026-04-03 | 59.18% | N/A | $0.68 | $52.35 |
| 2026-04-02 | 59.18% | N/A | $0.68 | $52.35 |
| 2026-04-01 | 59.18% | N/A | $0.68 | $52.35 |
| 2026-04-01 | 68.66% | N/A | N/A | $36.99 |
| 2026-04-01 | 68.66% | N/A | N/A | $36.99 |
Reports Featuring SLNO
EPS revision data sourced from analyst consensus estimates, refreshed daily. Soleno Therapeutics Inc (SLNO) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports